MedTrace Logo

Optical Coherence Tomography in STEMI

NCT02791178 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2016-06-06

No results posted yet for this study

Summary

The overall objective of this research proposal is to use OCT to investigate those morphological culprit plaque characteristics associated with the risk of developing MVO in reperfused STEMI patients.

Conditions

  • STEMI

Interventions

PROCEDURE

Optical coherence tomography (OCT)

Special camera to study part of your heart that was affected

PROCEDURE

Index of microcirculatory resistance (IMR)

Special wire to study part of your heart that was affected

OTHER

Cardiac MRI

Special scanner if the heart to assess the damage of your heart

Sponsors & Collaborators

  • National Heart Centre Singapore

    lead OTHER

Principal Investigators

  • Derek Hausenloy · National Heart Centre Singapore

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02791178 on ClinicalTrials.gov